The UK Joint Committee on Vaccination and Immunisation (JCVI) recommends the use of herpes zoster (shingles) vaccine in adults between 70 and 79 years provided that a licensed vaccine is available at a cost effective price. The full statement will be issued soon.

Please find the short statement at: http://www.dh.gov.uk/dr_consum_dh/groups/dh_digitalassets/@dh/@ab/documents/digitalasset/dh_111689.pdf